🤖 AI Summary
This study addresses the diagnostic challenge posed by the symptomatic overlap between dementia and depression in older adults by proposing a parallel assessment framework based on open-source large language models (e.g., Mistral 3.1, DeepHermes, and Qwen3). Leveraging transcribed speech from standardized clinical interviews—including pause information—the work introduces a novel Global Depression Scale aligned with the Global Deterioration Scale to enable concurrent staging of affective and cognitive symptoms. Under both zero-shot inference and support vector regression–based feature extraction paradigms, the models achieve strong performance, yielding mean absolute errors of 0.60 for depression and 0.78 for dementia severity estimation; the latter represents a 35% reduction in error compared to baseline methods. Notably, model performance using automatically generated transcripts matches that of manually transcribed ones.
📝 Abstract
Dementia and depression are the most prevalent neuropsychiatric disorders in geriatric populations, and their overlapping symptoms pose major challenges for differential diagnosis. In this study, we investigate open-weights Large Language Models (LLMs) for predicting dementia and depression severity from speech samples collected during standardized history taking interviews with 154 German-speaking subjects. We introduce an observer-based Global Depression Scale (GDS-D) aligned with the established Global Deterioration Scale (GDS), enabling parallel global staging of affective and cognitive symptoms. We compare three LLMs (Mistral 3.1, DeepHermes, Qwen3) in two settings: (1) zero-shot prediction and (2) LLM-based feature extraction for Support Vector Regression, using human and pause-enriched transcripts. Results show that LLMs effectively predict depression severity in zero-shot settings (best MAE of 0.60), while dementia assessment benefits substantially from structured feature extraction (best MAE of 0.78), reducing errors by up to 35% over zero-shot baselines. Pause-enriched transcripts achieve competitive performance with human transcriptions, demonstrating the viability of fully automatic screening pipelines for differential neuropsychiatric assessment.